





Touyz, R. M., Feldman, R. D., Harrison, D. G. and Schiffrin, E. L. (2020) A new look at 
the mosaic theory of hypertension. Canadian Journal of Cardiology, 36(5), pp. 591-592. 
 
   
There may be differences between this version and the published version. You are 




http://eprints.gla.ac.uk/215665/               






























Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk  
  
A new look at the mosaic theory of hypertension 
 
Rhian M Touyz MD, PhD1, Ross D. Feldman, MD2-3, David G. Harrison, MD4  




1Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow 
Cardiovascular Research Centre, University of Glasgow, UK. 
 
2Departments of Medicine, of Physiology & Pathophysiology, of Pharmacology & 
Therapeutics, University of Manitoba 
 
3Cardiac Sciences Program, Winnipeg Regional Health Authority 
Winnipeg, Manitoba, Canada 
 
4Vanderbilt University School of Medicine, Nashville, TN, USA 
 
5Lady Davis Institute for Medical Research, and Department of Medicine, Sir Mortimer 




To whom correspondence should be addressed: 
Rhian M Touyz MD, PhD 
Institute of Cardiovascular and Medical Sciences, 
BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 
126 University Place, Glasgow, G12 8TA, 
Phone: + 44 (0)141 330 7775/7774, Fax: + 44 (0)141 330-3360, 
Email: Rhian.Touyz@glasgow.ac.uk 
  
Despite extensive research, the pathogenesis of hypertension is still elusive. While 
the origin is known in less than 5% of patients, the majority of patients have primary 
hypertension, where identifiable cause(s) remain unknown. However, what is clear is 
that the pathophysiology of primary hypertension is multifactorial, multifaceted, highly 
complex and includes several interacting physiological systems. This was already 
highlighted over 70 years ago (1), when Irving H. Page suggested in his ‘mosaic 
theory’ that hypertension is a disease of ‘dysregulation’ that involves multiple 
interacting elements (Black elements, Figure). This was subsequently conceived as 
an octagon with regulators on each point, connected by arrows. This paradigm was 
refined 32 years later (2) to include genetic, environmental, anatomical, adaptive, 
neural, endocrine, humoral and hemodynamic factors as the pivotal components of 
the octagon (Blue elements, Figure).  
 
Since then there has been enormous progress in unravelling molecular, cellular and 
organ system mechanisms that underlie hypertension. Moreover it has become 
evident that the development of primary hypertension, from early to established and 
advanced stages, involves a range of cardiovascular and renal mechanisms ranging 
from the dysregulation of fetal/neonatal renal programming, the elevation in cardiac 
output that is characteristic of the elevations in blood pressure in adolescents and 
young adults to the increased peripheral resistance that is the hallmark of established 
and advanced hypertension.  
 
With advancements in hypertension research, it has become necessary to reconsider 
the comprehensiveness of the hypertension mosaic.  This was highlighted in 2013 in 
a paper entitled ‘The mosaic theory revisited’ (3). In the current issue, we further 
develop the concept with a collection of reviews focusing on some new aspects (Red 
elements, Figure) related to: genomics (4), sex hormones (5), the sympathetic nervous 
system (6), the brain aminopeptidase system (7), hyperinsulinemia and insulin 
resistance (8), oxidative stress (9), inflammation (10), the angiotensin AT2 receptor 
(11) and structure, mechanics and function of the vasculature (12).  
 
This compendium of reviews, together with the two papers on hypertension guidelines 
(13,14), provides state-of-the art knowledge that will keep the reader abreast of the 
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Different aspects of Irving Page’s mosaic theory of hypertension revisited in this 
compendium. The 4 black elements are the principal components mentioned in the 
original 1949 paper (1). The 8 blue components are enumerated in the subsequent, 
more extensive revisiting of the theme in 1982 (2). The 8 red components are themes 
dealt with by review papers in the present Theme Issue of the Canadian Journal of 
Cardiology. 
 
 
 
